At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
Dr. Ali Yehia from Fluxion Biosciences, South San Francisco CA, discusses the unique capabilities of the IonFlux system in facilitating assay development for PAM screening. The webinar focuses on the fast fluidics replacement and the successive liquid displacement facilitated by the continuous flow of extracellular media, a distinctive characteristic of the IonFlux system among all Automated Patch Clamp systems. The webinar was presented in 2014 as part of the Molecular Devices Ion Channels Webinar series.